| Literature DB >> 28233870 |
Jung-Yeon Choi1, Kwan-Jae Cho2, Sun-Wook Kim1,3, Sol-Ji Yoon1, Min-Gu Kang1, Kwang-Il Kim1,3, Young-Kyun Lee4, Kyung-Hoi Koo2,4, Cheol-Ho Kim1,3.
Abstract
High mortality and dependent living after hip fracture pose a significant public health concern. Retrospective study was conducted with 481 hip fracture patients (≥65 years of age) undergoing surgery from March 2009 to May 2014. The Hip-MFS was calculated by Comprehensive Geriatric Assessment (CGA). The primary outcome was the 6-month all-cause mortality rate. The secondary outcomes were 1-year all-cause mortality, postoperative complications and prolonged hospital stay, and institutionalization. Thirty-five patients (7.3%) died within 6 months after surgery (median [interquartile range], 2.9 [1.4-3.9] months). The fully adjusted hazard ratio per 1 point increase in Hip-MFS was 1.458 (95% confidence interval [CI]: 1.210-1.758) for 6-months mortality and odds ratio were 1.239 (95% CI: 1.115-1.377), 1.156 (95% CI: 1.031-1.296) for postoperative complications and prolonged total hospital stay, respectively. High-risk patients (Hip-MFS > 8) showed higher risk of 6-month mortality (hazard ratio: 3.545, 95% CI: 1.466-8.572) than low-risk patients after adjustment. Hip-MFS successfully predict 6-month mortality, postoperative complications and prolonged hospital stay in elderly hip fracture patients after surgery. Hip-MFS more precisely predict 6-month mortality than age or existing tools (P values of comparison of ROC curve: 0.002, 0.004, and 0.044 for the ASA classification, age and NHFS, respectively).Entities:
Mesh:
Year: 2017 PMID: 28233870 PMCID: PMC5324046 DOI: 10.1038/srep42966
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Composition of Hip-Multidimensional Frailty Score (Hip-MFS).
| Item | Score | ||
|---|---|---|---|
| 0 | 1 | 2 | |
| Sex | Female | Male | NA |
| Charlson Comorbidity Index | 0 | 1–2 | >2 |
| Albumin, g/dL | >3.9 | 3.5–3.9 | <3.5 |
| Koval grade | 1 | 2–6 | 7 |
| Dementia (MMSE-KC) | Normal | Mild cognitive impairment | Dementia |
| Risk of falling | Yes | No | NA |
| MNA | Normal | Risk of Malnutrition | Malnutrition |
| Midarm circumference, cm | >27 | 24.6–27.0 | <24.6 |
| Total score: 14, Cut-off values identifying high risk: >8 | |||
*The score of Prediction for Falling assessment guide more than 10 (>10) defined as a risk of falling.
MMSE-KC indicates Korean version of the Mini-Mental State Examination; MNA, Mini Nutritional Assessment.
Comparison of Demographic, Laboratory, and CGA Components by 6-month All-cause Mortality.
| Survival (n = 446) | Death (n = 35) | ||
|---|---|---|---|
| Age (year) | 80.3 (6.9) | 82.5 (6.8) | 0.073 |
| Sex (male/female) | 125/321 | 14/22 | 0.132 |
| Weight (kg) | 52.8 (10.6) | 51.3 (8.4) | 0.397 |
| Body mass index (kg/m2) | 21.5 (3.6) | 20.5 (3.1) | 0.115 |
| ASA class (1/2/3/4) | 29/274/126/4 | 0/14/21/0 | |
| Fracture site (intra/extra) | 217/229 | 18/17 | 0.752 |
| Anesthesia (general/spinal) | 49/397 | 5/30 | 0.575 |
| WBCs (×103/μL) | 9.5 (3.7) | 9.2 (3.1) | 0.639 |
| Hemoglobin (g/dL) | 11.6 (1.8) | 10.6 (2.0) | |
| Platelets (×103/μL) | 201.9 (74.6) | 217.2 (107.4) | 0.413 |
| Creatinine (mg/dL) | 0.97 (0.97) | 1.62 (1.82) | |
| Protein (mg/dL) | 6.5 (0.7) | 6.2 (0.7) | |
| Albumin (mg/dL) | 3.8 (0.5) | 3.4 (0.5) | < |
| AST (IU/L) | 24.9 (10.3) | 25.8 (10.3) | 0.613 |
| ALT (IU/L) | 17.4 (17.1) | 17.1 (12.2) | 0.916 |
| Charlson’s comorbidity index | 1.2 (1.3) | 2.4 (2.0) | |
| Polypharmacy | 348 (78.2%) | 28 (80.0%) | 0.804 |
| ADL dependency (partial and full) | 370 (83.0%) | 33 (94.3%) | 0.095 |
| IADL dependency | 336 (75.3%) | 34 (97.1%) | |
| MMSE-KC | 18.1 (7.6) | 13.3 (7.0) | |
| SGDS-K | 4.9 (3.3) | 5.0 (3.5) | 0.848 |
| Risk of fall (≥10) | 327 (73.3%) | 33 (94.3%) | |
| MNA | 20.7 (5.0) | 17.3 (5.1) | |
| Mid-arm circumference (cm) | 23.6 (3.1) | 21.6 (4.2) | |
| The Koval grade | 2.2 (1.8) | 3.4 (2.0) | |
Data are presented as mean (SD) or number (%).
ADL indicates activities of daily living; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ASA, American Society of Anesthesiologists; CGA, comprehensive geriatric assessment; IADL, instrumental activities of daily living; MMSE-KC, Korean version of the mini-mental status examination; SGDS-K, short form of the Korean Geriatric Depression Scale; MNA, mini nutritional assessment; Nu-DESC, the nursing delirium screening scale; WBC, white blood cell.
*Data were missing for 13 patients.
†Data were missing for 1 patient.
‡Data were missing for 59 patients.
§Data were missing for 140 patients.
Adjusted HRs by Score of Multidimensional Frailty Model for 6-Month Mortality, 1-year Mortality and ORs for Postoperative Complication, Institutionalization and Prolonged Hospital Stay Using Logistic Regression.
| Age adjusted OR (95% CI) | Fully Adjusted OR (95% CI) | |
|---|---|---|
| 6-month mortality | 1.560 (1.333–1.827)‡ | 1.458 (1.210–1.758)‡ |
| 1-year mortality | 1.415 (1.266–1.581)‡ | 1.419 (1.239–1.626)‡ |
| Postoperative complications | 1.295 (1.186–1.415)‡ | 1.239 (1.115–1.377)‡ |
| Institutionalization | 1.166 (1.075–1.265)‡ | 1.078 (0.978–1.191) |
| Prolonged total hospital stay | 1.215 (1.102–1.339)‡ | 1.187 (1.053–1.339)|| |
| Prolonged postoperative hospital stay | 1.211 (1.104–1.328)‡ | 1.135 (1.014–1.271)¶ |
*Adjusted by age, body mass index, white blood cell count, hemoglobin, cholesterol, protein, blood urea nitrogen, creatinine, and American Society of Anesthesiologists class.
†A total of 183 patients (38.0%) experienced at least 1 postoperative complication including pneumonia (21 patients), urinary tract infection (20 patients), pulmonary thromboembolism (4 patients), deep vein thrombosis (5 patients), delirium (162 patients), stroke (3 patients), and unplanned ICU admission (18 patients).
‡P < 0.001, ||P < 0.01, ¶P < 0.05. CI, indicates confidence interval; ICU, intensive care unit; HR, hazard ratio; OR, odds ratio.
Figure 1Cumulate 6-month survival rate according to risk stratification based on the Hip-MFS.
The Kaplan Meier curve for the cumulative 6-month all-cause survival rates between high risk and low risk Hip-MFS groups. Log-rank test shows significant difference between two groups, statistically.
Figure 2(A) Rates of 6-month all-cause mortality, complications, institutionalization. (B) Total and postoperative length of hospital stay. Adverse outcomes including 6-month mortality rate, postoperative complication rate, institutionalization rate and length of hospital stay are tend to increase in tandem with the Hip-MFS.
Comparison of 6-month mortality according to Hip-MFS risk group stratified by time to surgery.
| Low risk Hip-MFS (Hip-MFS ≤ 8) (n = 314) | High risk Hip-MFS (Hip-MFS > 8) (n = 117) | ||
|---|---|---|---|
| 1/38 (2.6%) | 3/6 (50.0%) | <0.001 | |
| 11/289 (3.8%) | 16/98 (16.3%) | <0.001 |
Total 431 patients were included for analysis.
*44 patients were included for analysis.
†387 patients were included for analysis.
§P value by log-rank test.
Figure 3Comparison of area under receiver operating characteristic curve (AUC) for 6-month all-cause mortality rate between Hip-MFS, age, ASA classification and NHFS.
Graph showing highest AUC area in Hip-MFS (0.78) than age (0.58), ASA classification (0.67) and NHFS (0.70) with statistical significance with p value of 0.049, 0.001 and 0.033, respectively.